OTGL yields 1.79% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, OTGL + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OTGL + MRK for your $10,000?
OTGL is actively managed, primarily investing in Latin American equity securities across the broad market-cap spectrum. Generally, Latin American countries are considered developing or emerging markets. Up to 20% of the portfolio may be allocated in stocks outside Latin America. Securities of the fund include a mix of common stocks, preferred stocks, convertible securities, depository receipts, ETFs, and investment fund shares. Leveraged and inverse ETFs may be used for short-term trading or hedging, with daily resets to meet objectives. The fund may experience high portfolio turnover, which could increase costs and impact performance. It may also concentrate investments in specific countries, which can change over time. OTGL converted from a mutual fund to an ETF, launching with $18.65 million in net assets.
Full OTGL Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.